Aprea Therapeutics (APRE) Stock Chart & Stock Price History $1.75 +0.05 (+2.94%) Closing price 07/3/2025 01:56 PM EasternExtended Trading$1.75 0.00 (0.00%) As of 07/3/2025 04:43 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Aprea Therapeutics Stock Price Performance The Aprea Therapeutics (APRE) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 54.78%, with a year-to-date return of -46.81%. In the past month, the stock has decreased 9.79%, reflecting recent market activity. As of the latest close, Aprea Therapeutics traded at $1.75 with a market cap of $9.68 million and volume of 9,119 shares. Receive APRE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aprea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+4.48%1 Month Performance-9.79%3 Month Performance+2.94%Year-To-Date Performance-46.81%1 Year Performance-54.78% APRE Stock Chart for Friday, July, 4, 2025 APRE Chart by TradingView Aprea Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/03/2025$1.70$1.75+2.94%$1.79$1.739,119 shs$9.68 million07/02/2025$1.65$1.70+3.03%$1.81$1.6533,450 shs$9.40 million07/01/2025$1.69$1.65-2.37%$1.72$1.6438,799 shs$9.12 million06/30/2025$1.68$1.69+0.90%$1.81$1.6842,645 shs$9.35 million06/27/2025$1.75$1.68-4.42%$1.80$1.6648,734 shs$9.26 million06/26/2025$1.80$1.75-2.64%$1.84$1.6382,482 shs$9.69 million06/25/2025$1.63$1.80+10.77%$1.91$1.48489,159 shs$9.95 million06/24/2025$1.60$1.63+1.56%$1.69$1.5817,489 shs$8.99 million06/23/2025$1.64$1.60-2.14%$1.67$1.5124,029 shs$8.85 million06/20/2025$1.77$1.64-7.51%$1.78$1.6230,352 shs$9.04 million Get the Latest News and Ratings for APRE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Aprea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/19/2025$1.77$1.77$1.88$1.759,016 shs$9.78 million06/18/2025$1.76$1.77+0.72%$1.88$1.759,016 shs$9.78 million06/17/2025$1.77$1.76-0.85%$1.90$1.789,168 shs$9.71 million06/16/2025$1.89$1.77-6.35%$1.87$1.7711,581 shs$9.79 million06/13/2025$1.92$1.89-1.56%$1.96$1.848,715 shs$10.45 million06/12/2025$1.88$1.92+1.91%$1.94$1.7616,434 shs$10.62 million06/11/2025$1.86$1.88+1.29%$1.99$1.8221,128 shs$10.42 million06/10/2025$1.84$1.86+1.09%$1.98$1.7727,709 shs$10.29 million06/09/2025$1.75$1.84+5.14%$1.87$1.7716,854 shs$10.18 million06/06/2025$1.81$1.75-3.31%$1.87$1.7524,171 shs$9.68 million06/05/2025$1.94$1.81-6.70%$2.00$1.8131,894 shs$10.01 million06/04/2025$1.81$1.94+6.95%$1.95$1.8319,941 shs$10.73 million06/03/2025$1.80$1.81+0.78%$1.95$1.7539,038 shs$10.03 million Related Companies BRNS Stock Chart MRSN Stock Chart ARTV Stock Chart ELYM Stock Chart XLO Stock Chart ATHE Stock Chart LVTX Stock Chart LTRN Stock Chart CLNN Stock Chart RNTX Stock Chart Receive APRE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Aprea Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:APRE) was last updated on 7/4/2025 by MarketBeat.com Staff From Our Partners[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredHave you heard of “E.I.”?Inside Expert: New "E.I." Tech Could Be Poised For 200,000% Growth Meta, Apple, and even NASA are rushing t...Behind the Markets | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aprea Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aprea Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
